
Novartis investing $23B on US manufacturing, R&D buildup
Amid renewed threats of import tariffs on pharmaceuticals from the Trump administration, Novartis plans to spend $23 billion over the next five years to expand its manufacturing, research and technology presence in the U.S. In an April 10 press release …